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Abstract
 
Myotonic dystrophy (DM), the most prevalent muscular
 
disorder in adults, is caused by (CTG)
 
n
 
-repeat expansion in
a gene encoding a protein kinase (DM protein kinase;
DMPK) and involves changes in cytoarchitecture and ion
homeostasis. To obtain clues to the normal biological role of
DMPK in cellular ion homeostasis, we have compared the
 
resting [Ca
 
2
 
1
 
]
 
i
 
, the amplitude and shape of depolarization-
induced Ca
 
2
 
1
 
 transients, and the content of ATP-driven ion
pumps in cultured skeletal muscle cells of wild-type and
 
DMPK[
 
2
 
/
 
2
 
] knockout mice.
In vitro–differentiated DMPK[
 
2
 
/
 
2
 
] myotubes exhibit a
higher resting [Ca
 
2
 
1
 
]
 
i
 
 than do wild-type myotubes because
 
of an altered open probability of voltage-dependent 
 
L
 
-type
Ca
 
2
 
1
 
 and Na
 
1
 
 channels. The mutant myotubes exhibit
smaller and slower Ca
 
2
 
1
 
 responses upon triggering by ace-
tylcholine or high external K
 
1
 
. In addition, we observed
that these Ca
 
2
 
1
 
 transients partially result from an influx of
extracellular Ca
 
2
 
1
 
 through the 
 
L
 
-type Ca
 
2
 
1
 
 channel. Neither
the content nor the activity of Na
 
1
 
/K
 
1
 
 ATPase and sarco-
plasmic reticulum Ca
 
2
 
1
 
-ATPase are affected by DMPK ab-
sence.
In conclusion, our data suggest that DMPK is involved in
modulating the initial events of excitation–contraction cou-
 
pling in skeletal muscle. (
 
J. Clin. Invest.
 
 1997. 100:1440–
 
1447.) Key words: excitation-contraction coupling 
 
•
 
 ion
channels 
 
•
 
 ion pumps 
 
•
 
 knockout mouse 
 
•
 
 cultured myo-
tubes
 
Introduction
 
Myotonic dystrophy (DM)
 
1
 
 follows an autosomal dominant in-
heritance, and is characterized by a wide variety of symptoms,
including increased excitability and delayed relaxation of mus-
cle, muscle weakness and wasting, ocular cataract, sensorineu-
ral deafness, cardiac conduction defects, hypersomnia, testicu-
lar atrophy causing male sterility, and endocrine dysfunction
(1). Clinical manifestation of this rather frequent disorder is
caused by expansion of an unstable CTG-repeat in the 3
 
9
 
-
untranslated region of a gene encoding the myotonic dystrophy
protein kinase (DMPK), with the age of onset and the severity
of the disease being correlated to the extent of expansion (2–4).
Contradictory results have been obtained with regard to
the effects of abnormally long CTG repeats on DMPK mRNA
and protein levels in patient tissues (5–8). In addition, the
study of transgenic mouse models with altered DMPK levels
(9, 10) has not provided the answer on the question whether
over- or underexpression of this protein is involved in disease
etiology. Homozygous DMPK[
 
2
 
/
 
2
 
] mice exhibit only minor
changes in neck muscle fibres at older age, whereas animals
carrying multiple copies of the DMPK transgene show hyper-
trophic cardiomyopathy and enhanced neonatal mortality as
the only features.
Typically, muscle fibers and/or cultured skeletal muscle
cells of DM patients exhibit a decreased resting membrane po-
 
tential (11–13) and increased basal cytosolic Na
 
1
 
 and Ca
 
2
 
1
 
concentrations (14–16). These features may be attributed to
anomalies in the functioning of voltage-operated Na
 
1
 
 channels
(17, 18) and Ca
 
2
 
1
 
 channels (15, 16) and/or to a reduced content
of Na
 
1
 
/K
 
1
 
-ATPase and sarcoplasmic reticulum (SR) Ca
 
2
 
1
 
-
ATPase (19, 20). In addition, the persistence of an apamin-
receptor, i.e. Ca
 
2
 
1
 
-activated K
 
1
 
 channel, has been demon-
strated (21).
Many of these ion channels and ion pumps are key players
in the excitation–contraction (E-C) coupling mechanism of
skeletal muscle in vivo, a cascade of events in which, sequen-
tially, acetylcholine receptors (AChR) of the neuromuscular
junction, sarcolemmal tetrodotoxin-sensitive voltage-oper-
ated Na
 
1
 
 channels (TTXR), T-tubular dihydropyridine recep-
tors (DHPR), and finally ryanodine receptors (RyR), i.e. Ca
 
2
 
1
 
release channels in the terminal cisternae of the SR, are in-
volved (22). E-C coupling of vertebrate skeletal muscle is
thought to occur by a mechanical coupling, in which intramem-
brane charge movements and associated conformational
changes of the voltage-sensing DHPR activate the RyR with-
out entry of external Ca
 
2
 
1
 
 through DHPR (23–25). Before re-
laxation, the disturbed ion concentrations are restored to rest-
ing levels by ATP-driven ion pumps, i.e., Na
 
1
 
/K
 
1
 
-ATPase and
SR Ca
 
2
 
1
 
-ATPase.
This whole process is subject to complex regulation in
which local luminal and cytosolic Ca
 
2
 
1
 
 and ATP levels are in-
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i
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volved. It is also influenced by protein phosphorylation and
ion channel–modulating proteins like FK506, triadin, or calse-
questrin. Since dysregulation of ion fluxes is a likely determin-
ing factor in the abnormal cellular functions in DM, and since
DMPK-mediated protein phosphorylation could play a role,
we examined if and how DMPK deficiency affects the depolar-
ization behavior and Ca
 
2
 
1
 
 homeostasis in cultured skeletal
muscle cells in the absence or presence of specific inhibitors of
the voltage-operated ion channels or the SR Ca
 
2
 
1
 
 release
channel. We also determined the activity and content of SR
Ca
 
2
 
1
 
-ATPase and Na
 
1
 
/K
 
1
 
-ATPase in cultured muscle cells
and skeletal muscle of wild-type and DMPK[
 
2
 
/
 
2
 
] mice. Al-
though the morphological and physiological effects of DMPK
absence at the animal level are surprisingly mild, we demon-
strate here, that DMPK deficiency has conspicuous conse-
quences at the cellular level. Our finding of abnormally operat-
ing TTXRs and DHPRs gives evidence for a relation between
DMPK activity and ion homeostasis in skeletal muscle.
 
Methods
 
Materials.
 
The acetoxymethyl ester of Fura-2 (Fura-2/AM) was pur-
chased from Molecular Probes Europe (Leiden, The Netherlands);
acetylcholine chloride (ACh), tetrodotoxin (TTX), ryanodine and
ionomycin were from Sigma (St. Louis, MO, USA); and nifedipine
from Bayer (Leverkusen, Germany). Sources of other materials were
described previously (20, 26).
 
DMPK-deficient mice.
 
Homozygous DMPK-deficient (DMPK[
 
2
 
/
 
2
 
])
mice were generated by targeted mutagenesis and genotyped by PCR
analysis as described (9). DMPK[
 
2
 
/
 
2
 
] animals from the F3 genera-
tion (on a mixed C57BL/6 
 
3
 
 129/OLA 50-50% background) were
used. Wild-type animals from the C57BL/6 inbred strain, and from a
colony with a C57BL/6 
 
3
 
 129/OLA mixed background were taken as
controls.
 
Cytosolic Ca
 
2
 
1
 
 concentration measurement in cultured skeletal
muscle cells.
 
Hind leg muscles of 3–10-d-old wild-type and DMPK[
 
2
 
/
 
2
 
]
mice were dissociated, and the isolated satellite cells were allowed to
proliferate for 2 d, and were then cultured under differentiation-pro-
moting conditions for 4 d on collagen-coated glass coverslips (
 
f
 
 25
mm) in serum-containing media, as described for human muscle cells
(26). The free cytosolic Ca
 
2
 
1
 
 concentration ([Ca
 
2
 
1
 
]
 
i
 
) and the effects of
depolarization induced by the addition of 20 
 
m
 
M ACh or 125 mM
KCl on [Ca
 
2
 
1
 
]
 
i
 
 were measured in single cells with Fura-2 using con-
ventional fluorescence video microscopy (26). For calibration, Ca
 
2
 
1
 
-
saturated or Ca
 
2
 
1
 
-free dye was set by 2 
 
m
 
M ionomycin in the presence
of 1.8 mM Ca
 
2
 
1
 
 (pH 7.5) or 20 mM EGTA (pH 8.0), respectively. Un-
der these conditions the myotubes remain attached to the coverslip.
Although the calibration parameters of wild-type and DMPK[
 
2
 
/
 
2
 
]
skeletal muscle cells did not differ significantly, we used these pa-
rameters strictly separated for calculation of [Ca
 
2
 
1
 
]
 
i
 
 to rule out cell-
type–dependent artefacts (27). The half-increase (
 
t
 
i
 
) and half-decay
time (
 
t
 
d
 
) of the depolarization-triggered Ca
 
2
 
1
 
 responses were ana-
lyzed as described (26, 28).
 
SR Ca
 
2
 
1
 
-ATPase and Na
 
1
 
/K
 
1
 
-ATPase.
 
The activity and concen-
tration of SR Ca
 
2
 
1
 
-ATPase were examined in homogenates of cul-
tured muscle cells (differentiated for 4 d) and hind leg skeletal muscle
of adult mice by measuring Ca
 
2
 
1
 
-dependent ATP hydrolysis and
steady-state phosphorylation, respectively (20). The activity of
Na
 
1
 
/K
 
1
 
-ATPase was assayed as the K
 
1
 
-dependent, ouabain-sensitive
3-
 
O
 
-methylfluorescein phosphatase (3-
 
O
 
-MFPase) activity and the
content of Na
 
1
 
/K
 
1
 
-ATPase was derived from the binding capacity of
[
 
3
 
H]ouabain (20).
 
Other procedures.
 
Creatine kinase (CK) activity of cultured mus-
cle cells (differentiated for 4 d) was determined with the CK 
 
N
 
-ace-
tylcysteine-activated monotest (26). For determining the percentage
CK muscle-specific isoenzyme MM (CK-MM), this isoenzyme was
 
separated from the other CK isoenzymes by gel electrophoresis (29).
The protein content was assayed according to Lowry et al. (30) with
BSA as a standard.
 
Statistics.
 
Data represent means
 
6
 
SD. Statistical analysis was per-
formed by means of the unpaired Student’s 
 
t
 
 test, and significance
was set at 
 
P
 
 
 
,
 
 0.05.
 
Results
 
General characteristics of cultured wild-type and DMPK[
 
2
 
/
 
2]
skeletal muscle cells. Upon differentiation, in vitro skeletal
muscle cells derived from wild-type and DMPK-deficient mice
exhibit a similar morphological appearance. Typically, the di-
ameter of these cells is z 10–20 mm, whereas their length var-
ies between 500 and 700 mm. Also, the total CK activity of
wild-type (1.9360.59 U/mg protein; n 5 11) and mutant cells
(1.8460.84 U/mg protein; n 5 5) and the percentage of CK-
MM, a measure for the overall maturation grade, are the
same for both cell types (wild-type: 33.8610.1; n 5 11, and
DMPK[2/2]: 37.165.8; n 5 5). Spontaneous contractions of
wild-type and DMPK[2/2] myotubes are occasionally observed
in culture, and occurred frequently upon agonist-induced de-
polarization in both cell types.
Ca21 homeostasis of wild-type skeletal muscle cells. The rest-
ing [Ca21]i of differentiated wild-type mouse skeletal muscle
cells in culture is 120 nM (Table I). Depolarization of the sar-
colemma of these cells either by 20 mM ACh or by 125 mM
KCl, induces Ca21 transients with an amplitude ([Ca21]i,max) of
z 0.8 mM (Fig. 1) and a ti and td of z 3 and 5 s, respectively.
The provoked Ca21 responses are completely prevented by in-
hibition of the SR Ca21 release channel (RyR) using 10 mM ry-
anodine (Fig. 2, B and C). Thus, Ca21 release from the SR is
entirely responsible for the increase of the [Ca21]i, indicating
that the wild-type myotubes possess a skeletal muscle type of
E-C coupling mechanism (28, 31). As anticipated, also ni-
fedipine (5 mM), a blocker of DHPR, impedes the depolariza-
tion-induced Ca21 transients (Fig. 3, B and C). Inhibition of
TTXR by 5 mM tetrodotoxin only partially suppresses depo-
larization by ACh (Fig. 4 B). This inhibition is incomplete due
to the coexistence of TTX-sensitive and TTX-resistant volt-
Table I. Ca21 Transients Induced by ACh or KCl in Cultured 
Skeletal Muscle Cells From Wild-type and DMPK[2/2] Mice
Stimulus Parameter Wild-type DMPK[2/2]
None [Ca21]i,basal 122617 185624*
(170) (63)
20 mM ACh [Ca21]i,max 7756131 5116124*
ti 3.060.6 6.661.9*
td 4.660.8 8.462.1*
(84) (38)
125 mM KCl [Ca21]i,max 8816164 5526130*
ti 3.260.7 6.161.7*
td 4.860.7 7.962.8*
(86) (25)
Values are means6SD of the number of muscle cells examined (listed
between parentheses) from at least four individual cultures. The valves
of [Ca21]i are expressed in nM, and the half-increase (ti) or half-decay
time (td) in s. Parameters of DMPK[2/2] and wild-type cells differ with
*P , 0.01.
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age-operated Na1 channels in cultured skeletal muscle cells
(28, 32). The K1-triggered Ca21 transients are not affected by
tetrodotoxin (Fig. 4 C), as expected. It is important to note
that neither of the three inhibitors have any effect on the rest-
ing [Ca21]i (Figs. 2 A, 3 A, and 4 A).
Depolarization of the cultured muscle cells in the absence
of extracellular Ca21 could not be performed, since the omis-
sion of external Ca21 before depolarization provokes a Ca21
transient (data not shown). As a result, the SR becomes at
least partially depleted for Ca21, which in turn can affect the
kinetics of the SR Ca21 release channel (33). In addition, the
DHPR may become inactivatable due to a loss in occupancy of
its priming site (23, 25).
Ca21 homeostasis of DMPK[2/2] skeletal muscle cells.
Surprisingly, the resting [Ca21]i (185 nM) of DMPK[2/2] skel-
etal muscle cells in culture is significantly higher than in wild-
type cells (Table I, Fig. 1). Ryanodine does not affect this
elevated level (Fig. 2 A), but nifedipine and tetrodotoxin nor-
malize the increased resting [Ca21]i completely or partially, re-
spectively (Figs. 3 A and 4 A). This means that DHPRs and
TTXRs are constitutively open in resting mutant skeletal mus-
cle cells, unlike in wild-type cells. Strikingly, the amplitudes of
the Ca21 responses provoked by depolarization with ACh or
KCl are reduced by about 40%, whereas τi and τd are increased
2- and 1.6-fold, respectively (Fig. 1). We observed that ryano-
dine reduces the depolarization-induced Ca21 responses in
DMPK[2/2] cells by only 90% (Fig. 2, B and C), whereas
complete blocking is achieved with nifedipine (Fig. 3, B and
C). This observation indicates that the Ca21 transients in these
cells partially result from an influx of extracellular Ca21
through the DHPRs. Tetrodotoxin incompletely inhibits ACh-
evoked Ca21 transients like in wild-type cells (Fig. 4 B). After
inhibition of TTXR by tetrodotoxin, when the basal [Ca21]i in
DMPK[2/2] cells has become lowered, the KCl-generated
Ca21 responses are both higher and faster than in the absence
of tetrodotoxin. The average amplitude of the Ca21 transients
raises z 140% and ti and td are reduced 1.5- and 1.6-fold, re-
spectively, and become similar to the values in wild-type cells
Figure 1. Depolarization-induced Ca21 transients in cultured skeletal muscle cells derived from wild-type (solid line) and DMPK[2/2] mice 
(dashed line). Depolarization was generated by 20 mM ACh (A) or 125 mM KCl (B) as marked by the bars. Traces show the average [Ca21]i after 
superimposing all appropriate experiments as listed in Table I.
Figure 2. Effects of ryanodine on resting [Ca21]i (A) and depolarization-provoked Ca
21 responses (B and C) in cultured wild-type and 
DMPK[2/2] muscle cells. Muscle cells were incubated with 10 mM ryanodine for 30 min before depolarization (B and C). Traces show the mean 
[Ca21]i after superimposing all relevant experiments as given in Table II. Ryanodine does not normalize the higher resting [Ca
21]i of DMPK[2/2] 
cells (A), and only partially inhibits depolarization-induced Ca21 transients (B and C).
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(compare Figs. 1 B and 4 C). Since these latter observations
suggest a [Ca21]i-regulated fine-tuning of depolarization-
induced Ca21 responses, we investigated whether there was
any relation between [Ca21]i and any of the parameters that
describe the shape and the magnitude of the Ca21 transients in
both cell types. The calculations clearly demonstrate that the
resting [Ca21]i inversely correlates with [Ca
21]i,max (Fig. 5 A),
and exhibits a high correlation with τi (Fig. 5 B). In addition, an
inverse correlation exists between [Ca21]i,max and td (Fig. 5 C).
The statistical evaluations of the depolarization-induced
Ca21 transients of both wild-type and mutant skeletal muscle
cells in the absence or presence of ion channel–specific inhibi-
tors are listed in Tables I and II, respectively, and sustain the
described phenomena.
SR Ca21-ATPase and Na1/K1-ATPase. The here observed
Ca21 homeostasis of cultured DMPK[2/2] mouse muscle cells
has the same characteristics as in cultured skeletal muscle cells
derived from DM patients (15, 16). Since muscle and cultured
muscle cells of patients have been shown to exhibit a lowered
activity of both SR Ca21-ATPase and Na1/K1-ATPase due to
a reduction of their content (20), we also examined these ATP-
driven ion pumps in our wild-type and mutant mice. As for
human (20), the activity and the concentration of SR Ca21-ATP-
ase as well as the K1-dependent, ouabain-sensitive 3-O-MFPase
activity and the ouabain-binding capacity, i.e., the number of
Na1/K1-ATPase molecules, are lower in cultured mouse mus-
cle cells than in mouse whole hind limb muscle, but the molec-
ular activities do not differ (Table III). Furthermore, pairwise
comparison between the two types of cultured muscle cells or
skeletal muscle of wild-type and DMPK[2/2] mice do not re-
veal any difference in the activity or content of SR Ca21-
ATPase and Na1/K1-ATPase (Table III).
Figure 3. Effects of nifedipine on resting [Ca21]i (A) and depolarization-generated Ca
21 transients (B and C) in cultured wild-type and 
DMPK[2/2] muscle cells. Muscle cells were incubated with 5 mM nifedipine for 30 min before depolarization (B and C). For other details, see 
legend to Fig. 2. Nifedipine completely normalizes the higher resting [Ca21]i of DMPK[2/2] cells (A).
Figure 4. Effects of tetrodotoxin on resting [Ca21]i (A) and depolarization-elicited Ca
21 responses (B and C) in cultured wild-type and 
DMPK[2/2] muscle cells. Muscle cells were preincubated with 5 mM tetrodotoxin for 30 min before depolarization (B and C). For other details, 
see legend to Fig. 2. Tetrodotoxin partially normalizes the higher resting [Ca21]i of DMPK[2/2] cells (A).
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Discussion
The focus of interest in DM research has slowly drifted from
the behavior of the instable (CTG)n repeat to the actual func-
tion(s) of individual genes in the mutant chromosome 19q
area. Three candidate genes for the DM locus have now been
characterized: DMR-N9, DMPK, and DMAHP (34, 35). As
the expanding repeat in DM actually interrupts the gene for
DMPK, most efforts in explaining disease etiology have been
directed towards the involvement of the product(s) of this sin-
gle gene. The results presented in this paper provide novel evi-
dence that there is a specific relationship between DMPK ac-
tivity and Ca21 homeostasis in skeletal muscle cells. Although
results from DMPK-cDNA transfection studies in BC3H1 cells
pointed to a function of DMPK in the myogenic pathway (36),
we conclude from study of the close-to-natural context pre-
sented here, that the sole absence of DMPK does not appear
to interfere with the growth and differentiation profiles of
muscle-derived satellite cells in vitro. Neither the morphologi-
cal appearance, nor the maturation grade, or the ability to con-
tract, differed between wild-type and mutant cells. Moreover,
our observations are in accordance with the absence of any
gross morphological and structural modifications in vivo in
mice that lack or overexpress the DMPK gene (9, 10).
The behavior of Ca21 homeostasis in cultured muscle cells
depends on DMPK activity. Estimates for resting [Ca21]i val-
ues of mouse skeletal muscle cells in culture clearly depend on
the cell origin, the Ca21 indicator used for assaying, and the cal-
ibration procedure applied. All we can say is that our value for
the resting [Ca21]i in cultured muscle cells of wild-type mice,
based on the in vivo calibration of Fura-2, falls well within the
range of values published for cultured mouse myotubes (37)
and myofibers in vivo (38). Since inhibition of the SR Ca21 re-
lease channel by ryanodine effectively blocks depolarization-
induced Ca21 efflux in cultured wild-type cells (Fig. 2, B and C),
these cells, like those of rats and humans, must possess a skele-
tal muscle type of E-C coupling mechanism, rather than a car-
diac muscle type, in which Ca21 release is provoked by an influx
of external Ca21 (28, 31). Moreover, it suggests that the contri-
bution of a Ca21 influx through the ion-unselective AChR (39),
the dihydropyridine-insensitive fast-activated voltage-operated
T-type Ca21 channel (40), and/or the slow-activated voltage-
dependent L-type Ca21 channel, i.e., DHPR (41), during depo-
larization is negligibly small, and/or is ineffective to induce
Ca21 release from the SR. This does not rule out that Ca21 en-
try via the DHPR may play a role in long-lasting depolariza-
tions in wild-type cells, but usually this process is slower than
the charge movement in DHPR and the associated activation
of the RyR (41).
The situation in mutant myotubes is clearly different in that
absence of DMPK augments the resting [Ca21]i, and has damp-
ening effects on the release and sequestration of Ca21 upon
depolarization. Application of inhibitors showed that the phe-
nomenon of higher resting [Ca21]i and the altered excitability
are somehow linked to the mode of action of voltage-depen-
dent Ca21 and Na1 channels. It is unlikely that a recently de-
scribed Ca21-specific leak channel is involved, as the situation
Figure 5. [Ca21]i-regulated fine-tun-
ing of Ca21 responses in cultured 
wild-type (open symbols) and 
DMPK[2/2] skeletal muscle cells 
(solid symbols). The relation is 
shown for the mean values of 
[Ca21]i,rest and [Ca
21]i,max (A) or ti 
(B), and for [Ca21]i,max and td (C). 
Data originate from Ca21 transients 
induced by 125 mM KCl in the ab-
sence (s, d) and presence of tetro-
dotoxin (h, j). The solid lines rep-
resent the regression curves, and 
the dotted lines mark the 99% confi-
dence intervals.
Table II. Effects of E-C Coupling Inhibitors on ACh- and 
KCl-induced Ca21 Transients in Cultured Skeletal Muscle Cells 
From Wild-type and DMPK[2/2] Mice
Inhibitor Stimulus Parameter Wild-type DMPK [2/2]
Ryanodine (10 mM) ACh [Ca21]i,basal 119621 182638*
[Ca21]i,max 119621 251631*
(40) (21)
KCl [Ca21]i,basal 120624 179639*
[Ca21]i,max 120624 248631*
(28) (17)
Nifedipine (5 mM) ACh [Ca21]i,basal 120623 127633
[Ca21]i,max 120623 127633
(42) (19)
KCl [Ca21]i,basal 121620 125629
[Ca21]i,max 121620 125629
(52) (32)
Tetrodotoxin (5 mM) ACh [Ca21]i,basal 120623 155636*
[Ca21]i,max 378656 351667
(29) (23)
KCl [Ca21]i,basal 116625 153640*
[Ca21]i,max 8266196 7196234
‡
(48) (45)
Values expressed in nM, are means6SD of the number of muscle cells
(listed between parentheses) from at least three individual cultures.
Concentrations of ACh and KCl are 20 mM and 125 mM, respectively.
Parameters of DMPK[2/2] and wild-type cells differ with *P , 0.01
and ‡P , 0.05. In the presence of tetrodotoxin ti of the KCl-evoked
Ca21 responses in wild-type and mutant cells are 3.160.9 s and 4.261.3 s
(P , 0.01), whereas td are 4.961.1 s and 5.561.5 s (P , 0.05), respec-
tively.
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is completely normalized by nifedipine, which fails to inhibit
this leak channel (42). Our mutant myotubes lack a protein ki-
nase that is closely related to the subfamilies of cAMP-depen-
dent protein kinases and protein kinases C (2, 43). Hence, it is
most likely that the phosphorylation status of the Ca21 and/or
Na1 channels or any other protein that mediates the clustering
of ion channels in the sarcolemma is modified in DMPK[2/2]
myotubes. In turn, this may change the gating properties of
these channels and/or influence the distribution and regulation
of voltage-dependent SR Ca21 release events (44). Impor-
tantly, phosphorylation of both the a1 and b subunits of the
DHPR is known to occur. Phosphorylation of the a1 subunit
leads to an increase of the Ca21 current (45), and we would
expect absence of phosphorylation to reduce this current, a
feature that is inconsistent with the observed high [Ca21]i in
resting DMPK[2/2] cells. Perhaps more relevant is that re-
combinant-DMPK can use the b-subunit as a substrate in vitro
(46), although the precise effects of phosphorylation of this
subunit, which regulates the a1-subunit activity (47), are un-
known. Similarly interesting is that phosphorylation of the a
subunit of the TTX-sensitive Na1 channel in cultured mouse
and rat muscle cells by protein kinase C and in transfected oo-
cytes by DMPK leads to a reduction of the Na1 current (48,
49). A persistent influx of Na1 as a consequence of DMPK ab-
sence may lead to mild long-lasting depolarization of the sar-
colemma, and results in a more frequent opening of the L-type
Ca21 channel. We cannot, however, exclude the possibility that
DMPK-mediated phosphorylation primarily influences the
gating by affecting the sarcolemmal and T-tubular architec-
ture, or is involved in the (in)activation of voltage-gated ion
channels that set the resting membrane potential, like K1 and
Cl2 channels. Delayed rectifier (50), inward rectifier (51), as
well as Ca21-activated K1 channels (52) can be phosphorylated
by cAMP-dependent protein kinase and/or protein kinase C in
heart, smooth muscles, and neurons. Activation of protein ki-
nase C reduces Cl2-conductance and leads to myotonia (53). It
is difficult to discriminate as ion channel regulation by phos-
phorylation is extremely complex (51, 54). Thus, although our
findings do not provide direct clues for any of these channels
being a direct target for DMPK, they illustrate a unique prop-
erty of DMPK, namely that it exerts a modulating function on
the initial events of the E-C coupling in skeletal muscle. The
localization of DMPK isoforms at sites of dense channel clus-
tering (55–57) is consistent with the fact that these processes
occur at or close to the sarcolemma.
Relevance for disease etiology? Since [Ca21]i is a crucial
regulator of many physiological processes, elevated [Ca21]i
could potentially have profound consequences in vivo. Can we
extrapolate our in vitro findings and relate abnormal Ca21 ho-
meostasis to disease manifestation in DM patients? We realize
that our knockout mouse and cell models do not provide a di-
rect answer to this question, as the effects of CTG expansion
on DMPK expression still have not been clearly resolved. The
mouse myotubes, however, do provide the ideal test system to
study the normal biological significance of DMPK against a
well-defined, constant genetic background. Earlier we dis-
cussed the apparent lack of an overt phenotype in our animal
model (9) in terms of possible adaptation, compensation, or
threshold effects, which in mice, with a relatively low muscle
workload due to small body weight, often obscure the manifes-
tation of myopathic features (58). Here we study the system in
isolation, outside the context of the entire tissue, and it is per-
haps more relevant that the elevated resting [Ca21]i , and the
effects on release and sequestration of Ca21 coupled to abnor-
mal regulation of TTX-sensitive Na1 channels and voltage-oper-
ated L-type Ca21 channels match the data obtained with myo-
tubes derived from DM patients (15–18). There are also
differences in that abnormal SR Ca21-ATPase and Na1/K1-
ATPase levels were not found in mouse DMPK[2/2] cells
(Table III, 20). It is possible that Ca21-dependent gene expres-
sion critical for these changes may have a differential threshold
sensitivity in man and mouse, and almost certainly there are
differential effects due to the completely distinct mutation type
in the human and mouse situation. For example, for DM pa-
tients it is conceivable that large expansions of the (CTG)n repeat
affect other genes in the immediate vicinity, like the down-
stream-located DMAHP gene which specifies a transcription
factor implemented in ion-channel expression regulation (35, 59).
Thus, although the cell model is clearly too simplistic, our
finding of similar disturbances in Ca21 homeostasis in muscle
cells of both DM patients and DMPK[2/2] mice lends indi-
rect support to the contention that the DM mutation results in
a reduction or redistribution of DMPK mRNA and protein
isoforms, in line with the molecular explanations provided by
others (8, 60, 61). In conclusion, our study provides new insight
in the relation between DMPK activity and Ca21 responsive-
Table III. SR Ca21-ATPase and Na1/K1-ATPase in Muscle and Cultured Muscle Cells of Wild-type and DMPK[2/2] Mice
Muscle Cultured muscle cells
Parameters Wild-type DMPK[2/2] Wild-type DMPK[2/2]
SR Ca21-ATPase activity (mU/mg protein) 76.267.4 (5) 75.964.5 (3) 13.162.3 (8) 13.361.8 (4)
SR Ca21-ATPase content (pmol/mg protein) 94.968.0 (5) 94.765.8 (3) 16.462.8 (8) 16.562.0 (4)
Molecular activity (min21) 802614 (5) 80169 (3) 80068 (8) 803613 (4)
Na1/K1-ATPase activity (mU/mg protein) 0.5760.06 (5) 0.5660.08 (3) 0.9360.09 (7) 0.9560.13 (4)
Na1/K1-ATPase content (pmol/mg protein) 6.360.6 (5) 6.260.2 (3) 10.160.7 (5) 10.461.6 (4)
Molecular activity (min21) 9167 (5) 89611 (3) 9268 (5) 9168 (4)
Values are means6SD of the number of muscles or muscle cell cultures (given between parentheses). The activity and content of SR Ca21-ATPase
were determined by Ca21-dependent ATP hydrolysis and steady-state phosphorylation, respectively. The K1-dependent, ouabain-sensitive hydrolysis
of 3-O-MFP and the binding capacity of ouabain were used as a measure for the activity and content of Na1/K1-ATPase, respectively.
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ness in skeletal muscle. The suggestion that DMPK modulates
the movement of gating charge and/or the activity of voltage-
gated ion channels opens up new possibilities for studies into
the molecular etiology of DM.
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